众兴菌业(002772) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥472,639,729.59, a decrease of 2.89% compared to the same period last year[4] - Net profit attributable to shareholders increased by 38.72% to ¥48,200,213.87, driven by reduced procurement costs and capitalized interest on construction projects[10] - Basic and diluted earnings per share rose by 45.25% to ¥0.1284[4] - Total operating revenue for the current period is $472.64 million, a decrease of 2.18% from $486.70 million in the previous period[21] - Operating profit increased to $47.87 million, up 39.63% from $34.32 million in the previous period[22] - Net profit for the current period is $47.89 million, a 39.36% increase compared to $34.40 million in the previous period[22] Cash Flow - The net cash flow from operating activities was ¥95,148,682.79, down 4.77% from the previous year[4] - Cash flow from operating activities generated a net amount of $95.15 million, down from $99.91 million in the previous period[23] - Cash flow from investing activities resulted in a net outflow of $56.54 million, compared to a net outflow of $30.98 million in the previous period[23] - Cash flow from financing activities generated a net inflow of ¥154,855,000, down from $410.13 million in the previous period[24] - The ending cash and cash equivalents balance is $1.38 billion, a decrease from $1.52 billion in the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period increased by 3.16% to ¥6,386,589,455.41[4] - As of March 31, 2025, the total assets of Tianshui Zhongxing Mushroom Industry Technology Co., Ltd. amounted to CNY 6,386,589,455.41, an increase from CNY 6,190,908,422.74 at the beginning of the period[17] - The company's total liabilities were CNY 3,037,523,672.05, compared to CNY 2,872,170,200.68 previously, indicating an increase of about 5.8%[18] - The company's total liabilities to equity ratio was approximately 0.91, indicating a stable leverage position[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 31,566[13] - The largest shareholder, Tao Jun, holds 28.01% of the shares, with 47,310,000 shares pledged[13] Expenses - Research and development expenses for Q1 2025 were ¥2,494,400, a decrease of 36.35% year-on-year[9] - Financial expenses decreased by 71.40% to ¥2,433,500 due to reduced interest expenses and capitalization of some project interests[10] Borrowings - Short-term borrowings decreased significantly to CNY 390,000,000.00 from CNY 615,463,056.95, a reduction of about 36.7%[18] - The company's long-term borrowings increased to CNY 1,453,466,923.50 from CNY 1,059,448,138.80, reflecting a growth of approximately 37.2%[18] Retained Earnings - The retained earnings rose to CNY 1,006,025,646.36 from CNY 957,825,432.49, an increase of about 5.0%[19]